Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophagus Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04499924
What this trial is testing

Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Seagen Inc. 17
Testing effectiveness (Phase 2)Ended earlyNCT02234180
What this trial is testing

Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionStage IIB Esophageal AdenocarcinomaStage IIIA Esophageal Adenocarcinoma+2 more
Academic and Community Cancer Research United 3
Testing effectiveness (Phase 2)Study completedNCT02971956
What this trial is testing

Pembrolizumab in Refractory Advanced Esophageal Cancer

Who this might be right for
Esophageal CancerSquamous Cell Esophagus CancerAdenocarcinoma Esophagus
Dana-Farber Cancer Institute 49
Testing effectiveness (Phase 2)Study completedNCT00040859
What this trial is testing

Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 48
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Testing effectiveness (Phase 2)UnknownNCT03542422
What this trial is testing

Apatinib as First -Line Treatment for Advanced Esophagus Cancer

Who this might be right for
Advanced Esophagus Cancer
Affiliated Hospital of North Sichuan Medical College 50
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)UnknownNCT05830097
What this trial is testing

Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Who this might be right for
Cancer, BreastCancer, LungCancer of Pancreas+2 more
Coherent Biopharma (Hefei) Co., Ltd. 260
Testing effectiveness (Phase 2)UnknownNCT03011255
What this trial is testing

Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsEsophageal DiseasesDigestive System Diseases
Shixiu Wu 20
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00258323
What this trial is testing

Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Case Comprehensive Cancer Center 80
Not applicableWithdrawnNCT00499291
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07233850
What this trial is testing

A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers

Who this might be right for
Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Shenyang Sunshine Pharmaceutical Co., LTD. 300
Not applicableLooking for participantsNCT05392413
What this trial is testing

Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody

Who this might be right for
Esophageal Squamous Cell CarcinomaPD-1 Inhibitor
Nanfang Hospital, Southern Medical University 200
Testing effectiveness (Phase 2)Study completedNCT00259402
What this trial is testing

Oxaliplatin in Esophagus Cancer (Advanced) 1st Line

Who this might be right for
Esophageal Neoplasms
Sanofi 41
Testing effectiveness (Phase 2)Looking for participantsNCT05187338
What this trial is testing

Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors

Who this might be right for
Lung CancerLiver CancerColorectal Cancer+8 more
Second Affiliated Hospital of Guangzhou Medical University 100
Large-scale testing (Phase 3)Study completedNCT04879368
What this trial is testing

RegoNivo vs Standard of Care Chemotherapy in AGOC

Who this might be right for
Gastro-Oesophageal Cancer
Australasian Gastro-Intestinal Trials Group 462
Testing effectiveness (Phase 2)Study completedNCT00154804
What this trial is testing

CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
National Taiwan University Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT04945733
What this trial is testing

Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer

Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
Janssen Pharmaceutical K.K. 62
Early research (Phase 1)Study completedNCT04695847
What this trial is testing

M1231 in Participants With Solid Tumors

Who this might be right for
Metastatic Solid TumorsEsophageal CancerNon-Small Cell Lung Cancer
EMD Serono Research & Development Institute, Inc. 23
Next Page